Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples